Group B streptococcal infection (English Wikipedia)

Where can I get the ECM test?. "ECM Testing". Group B Strep Support. Retrieved 22 November 2023.
GROUP B STREP SUPPORT. "FAQs35. Carrying GBS and home birth?". Retrieved 4 March 2021.
"Home Page". Group B Strep Support.

gnpi.de

"Prophylaxe der Neugeborenensepsis - frühe Form - durch Streptokokken der Gruppe B" (PDF). Retrieved 25 November 2023.

gov.uk

UK Gov. (26 June 2018). "SMI B 58: detection of carriage of group B streptococci. Updated 2018". Retrieved 28 February 2021.

handle.net

hdl.handle.net

Madhi SA (June 2023). "Potential for Maternally Administered Vaccines for Infant Group B Streptococcus". New England Journal of Medicine. 389 (3): 215–227. doi:10.1056/NEJMoa2116045. hdl:2263/94684. PMID 37467497. S2CID 259995252.

harvard.edu

ui.adsabs.harvard.edu

Roloff K, Stepanyan G , Valenzuela G (2018). "Prevalence of oropharyngeal group B Streptococcus colonization in mothers, family, and health care providers". PLOS ONE. 13 (9): e0204617. Bibcode:2018PLoSO..1304617R. doi:10.1371/journal.pone.0204617. PMC 6161895. PMID 30265687.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Gupalova T, Leontieva G, Kramskaya T, Grabovskaya K, Bormotova E, Korjevski D, Suvorov A (2018). "Development of experimental GBS vaccine for mucosal immunization". PLOS ONE. 13 (5): e0196564. Bibcode:2018PLoSO..1396564G. doi:10.1371/journal.pone.0196564. PMC 5935385. PMID 29727446.
Li LP, Wang R, Liang WW, Huang T, Huang Y, Luo FG, et al. (August 2015). "Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro". Fish & Shellfish Immunology. 45 (2): 955–963. Bibcode:2015FSI....45..955L. doi:10.1016/j.fsi.2015.06.014. PMID 26087276.
Zhang D, Gao Y, Li Q, Ke X, Liu Z, Lu M, Shi C (March 2020). "An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus)". Fish & Shellfish Immunology. 98: 853–859. Bibcode:2020FSI....98..853Z. doi:10.1016/j.fsi.2019.11.044. PMID 31751658. S2CID 208226408.

has-sante.fr

"Prévention anténatale du risque infectieux bactérien néonatal précoce" [Antenatal prevention of the risk of early neonatal bacterial infection] (PDF). Agence Nationale d'Accreditation et d'Evaluation en Santé [National Agency for Accreditation and Health Evaluation] (in French). 2001. Retrieved 2 March 2021.

ijidonline.com

Binghuai L, Yanli S, Shuchen Z, Fengxia Z, Dong L, Yanchao C (October 2014). "Use of MALDI-TOF mass spectrometry for rapid identification of group B Streptococcus on chromID Strepto B agar". International Journal of Infectious Diseases. 27: 44–48. doi:10.1016/j.ijid.2014.06.023. PMID 25220051.

jabfm.org

Hicks P, Diaz-Perez MJ (2009). "Patient self-collection of group B streptococcal specimens during pregnancy" (PDF). Journal of the American Board of Family Medicine. 22 (2): 136–140. doi:10.3122/jabfm.2009.02.080011. PMID 19264936. S2CID 2208746.

journalofdairyscience.org

Ruegg PL (December 2017). "A 100-Year Review: Mastitis detection, management, and prevention". Journal of Dairy Science. 100 (12): 10381–10397. doi:10.3168/jds.2017-13023. PMID 29153171. S2CID 6122209. Retrieved 26 November 2023.

lshtm.ac.uk

researchonline.lshtm.ac.uk

Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT (February 2012). "Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis". Lancet. 379 (9815): 547–556. doi:10.1016/s0140-6736(11)61651-6. PMID 22226047. S2CID 15438484.

lww.com

journals.lww.com

"Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797". Obstetrics and Gynecology. 135 (2): e51 – e72. February 2020. doi:10.1097/AOG.0000000000003668. PMID 31977795. S2CID 210891255.
Davies HG, Carreras-Abad C, Le Doare K, Heath PT (June 2019). "Group B Streptococcus: Trials and Tribulations". The Pediatric Infectious Disease Journal. 38 (6S Suppl 1): S72 – S76. doi:10.1097/INF.0000000000002328. PMID 31205250. S2CID 189943251. Retrieved 26 November 2023.

med-info.nl

"Preventie van neonatale groep-B-streptokokkenziekte (GBS-ziekte) Versie 2.0" [Prevention of Neonatal Group B Streptococcal Disease (GBS-Disease) Version 2.0] (PDF). Nederlandse Vereniging voor Obstetrie en Gynaecologie [Dutch Association for Obstetrics and Gynaecology] (in Dutch). Med-Info. 2008. Retrieved 25 November 2019.

medisave.co.uk

"Group B Streptococcus Screening Test". Medisave UK Ltd. Retrieved 20 November 2023.

minsalud.gov.co

"Resolución 3280" (PDF) (in Spanish). 2018. Retrieved 27 November 2023.

msal.gov.ar

e-legis-ar.msal.gov.ar

"Realización del examen de detección del estreptococo Grupo B Agalactiae, a todas las embarazadas con edad gestacional entre las semanas 35 y 37" (in Spanish). 2008. Retrieved 27 November 2023.

nice.org.uk

Screening for infections.1.8.9 Group B streptococcus (26 March 2008). "Antenatal care for uncomplicated pregnancies.NICE guidelines [CG62] : March 2008". NICE National Institute for Health and Care Excellence. Retrieved 27 November 2019.{{cite web}}: CS1 maint: numeric names: authors list (link)
"Recommendations | Antenatal care | Guidance | NICE". www.nice.org.uk. 19 August 2021. Retrieved 21 May 2022.
"Recommendations | Neonatal infection: antibiotics for prevention and treatment | Guidance | NICE". www.nice.org.uk. 20 April 2021. Retrieved 21 May 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Eickhoff TC, Klein JO, Daly AK, Ingall D, Finland M (December 1964). "Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci". The New England Journal of Medicine. 271 (24): 1221–1228. doi:10.1056/NEJM196412102712401. PMID 14234266.
Rosa-Fraile M, Spellerberg B (September 2017). "Reliable Detection of Group B Streptococcus in the Clinical Laboratory". Journal of Clinical Microbiology. 55 (9): 2590–2598. doi:10.1128/JCM.00582-17. PMC 5648696. PMID 28659318.
Filkins L, Hauser JR, Robinson-Dunn B, Tibbetts R, Boyanton BL, Revell P (December 2020). "American Society for Microbiology Provides 2020 Guidelines for Detection and Identification of Group B Streptococcus". Journal of Clinical Microbiology. 59 (1). doi:10.1128/JCM.01230-20. PMC 7771461. PMID 33115849.
Rosa-Fraile M, Rodriguez-Granger J, Cueto-Lopez M, Sampedro A, Gaye EB, Haro JM, Andreu A (August 1999). "Use of Granada medium to detect group B streptococcal colonization in pregnant women". Journal of Clinical Microbiology. 37 (8): 2674–2677. doi:10.1128/JCM.37.8.2674-2677.1999. PMC 85311. PMID 10405420.
Binghuai L, Yanli S, Shuchen Z, Fengxia Z, Dong L, Yanchao C (October 2014). "Use of MALDI-TOF mass spectrometry for rapid identification of group B Streptococcus on chromID Strepto B agar". International Journal of Infectious Diseases. 27: 44–48. doi:10.1016/j.ijid.2014.06.023. PMID 25220051.
To KN, Cornwell E, Daniel R, Goonesekera S, Jauneikaite E, Chalker V, Le Doare K (February 2019). "Evaluation of matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) for the Identification of Group B Streptococcus". BMC Research Notes. 12 (1): 85. doi:10.1186/s13104-019-4119-1. PMC 6376729. PMID 30764872.
El Aila NA, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H, et al. (September 2010). "Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women". BMC Infectious Diseases. 10: 285. doi:10.1186/1471-2334-10-285. PMC 2956727. PMID 20920213.
"Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797". Obstetrics and Gynecology. 135 (2): e51 – e72. February 2020. doi:10.1097/AOG.0000000000003668. PMID 31977795. S2CID 210891255.
Roloff K, Stepanyan G , Valenzuela G (2018). "Prevalence of oropharyngeal group B Streptococcus colonization in mothers, family, and health care providers". PLOS ONE. 13 (9): e0204617. Bibcode:2018PLoSO..1304617R. doi:10.1371/journal.pone.0204617. PMC 6161895. PMID 30265687.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Russell NJ, Seale AC, O'Driscoll M, O'Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al. (November 2017). "Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses". Clinical Infectious Diseases. 65 (suppl_2): S100 – S111. doi:10.1093/cid/cix658. PMC 5848259. PMID 29117327.
Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R (2008). "Prevalence of maternal group B streptococcal colonisation in European countries". Acta Obstetricia et Gynecologica Scandinavica. 87 (3): 260–271. doi:10.1080/00016340801908759. PMID 18307064. S2CID 25897076.
Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, et al. (September 2012). "Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project". European Journal of Clinical Microbiology & Infectious Diseases. 31 (9): 2097–2104. doi:10.1007/s10096-012-1559-0. PMID 22314410. S2CID 15588906.
Muller AE, Oostvogel PM, Steegers EA, Dörr PJ (2016). "Morbidity related to maternal group B streptococcal infections". Acta Obstetricia et Gynecologica Scandinavica. 85 (9): 1027–1037. doi:10.1080/00016340600780508. PMID 16929406. S2CID 11745321.
Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, et al. (July 2012). "Long-term outcomes of group B streptococcal meningitis". Pediatrics. 130 (1): e8-15. doi:10.1542/peds.2011-3453. PMID 22689869. S2CID 1013682.
Puopolo KM, Lynfield R, Cummings JJ (August 2019). "Management of Infants at Risk for Group B Streptococcal Disease". Pediatrics. 144 (2): e20191881. doi:10.1542/peds.2019-1881. PMID 31285392. S2CID 195843897.
Raabe, Vanessa N.; Shane, Andi L. (March 2019). "Group B Streptococcus (Streptococcus agalactiae)". Microbiology Spectrum. 7 (2): 10.1128/microbiolspec.GPP3–0007–2018. doi:10.1128/microbiolspec.GPP3-0007-2018. ISSN 2165-0497. PMC 6432937. PMID 30900541.
Boyer KM, Gotoff SP (1985). "Strategies for Chemoprophylaxis of GBS Early-Onset Infections1". Strategies for chemoprophylaxis of GBS early-onset infections. Antibiotics and Chemotherapy. Vol. 35. pp. 267–280. doi:10.1159/000410380. ISBN 978-3-8055-3953-1. PMID 3931544.
Polin RA (May 2012). "Management of neonates with suspected or proven early-onset bacterial sepsis". Pediatrics. 129 (5): 1006–1015. doi:10.1542/peds.2012-0541. PMID 22547779. S2CID 230591.
Martinez E, Mintegi S, Vilar B, Martinez MJ, Lopez A, Catediano E, Gomez B (May 2015). "Prevalence and predictors of bacterial meningitis in young infants with fever without a source". The Pediatric Infectious Disease Journal. 34 (5): 494–498. doi:10.1097/inf.0000000000000629. PMID 25461476. S2CID 43717212.
Russell NJ, Seale AC, O'Sullivan C, Le Doare K, Heath PT, Lawn JE, et al. (November 2017). "Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses". Clinical Infectious Diseases. 65 (suppl_2): S152 – S159. doi:10.1093/cid/cix655. PMC 5850448. PMID 29117325.
Dauby N, Chamekh M, Melin P, Slogrove AL, Goetghebuer T (2016). "Increased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible Mechanisms". Frontiers in Immunology. 7: 505. doi:10.3389/fimmu.2016.00505. PMC 5110531. PMID 27899925.
Baker CJ, Kasper DL (April 1976). "Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection". The New England Journal of Medicine. 294 (14): 753–756. doi:10.1056/nejm197604012941404. PMID 768760.
Baker CJ, Edwards MS, Kasper DL (October 1981). "Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection". Pediatrics. 68 (4): 544–549. doi:10.1542/peds.68.4.544. PMID 7033911. S2CID 38905874.
Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT (February 2012). "Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis". Lancet. 379 (9815): 547–556. doi:10.1016/s0140-6736(11)61651-6. PMID 22226047. S2CID 15438484.
Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, et al. (March 2019). "Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance". JAMA Pediatrics. 173 (3): 224–233. doi:10.1001/jamapediatrics.2018.4826. PMC 6439883. PMID 30640366.
Lin FY, Weisman LE, Troendle J, Adams K (July 2003). "Prematurity is the major risk factor for late-onset group B streptococcus disease". The Journal of Infectious Diseases. 188 (2): 267–271. doi:10.1086/376457. PMID 12854082.
Karampatsas K, Davies H, Mynarek M, Andrews N, Heath PT, Le Doare K. (2022). "Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-Analyses". Clin Infect Dis. 75 (7): 1255–1264. doi:10.1093/cid/ciac206. PMC 9525091. PMID 35275986.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Boyer KM, Gadzala CA, Kelly PD, Gotoff SP (November 1983). "Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission". The Journal of Infectious Diseases. 148 (5): 810–816. doi:10.1093/infdis/148.5.810. PMID 6355318.
Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB, Regan JA, et al. (May 2001). "The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease". American Journal of Obstetrics and Gynecology. 184 (6): 1204–1210. doi:10.1067/mob.2001.113875. PMID 11349189.
de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M (January 1998). "Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus". Obstetrics and Gynecology. 91 (1): 112–114. doi:10.1016/s0029-7844(97)00587-5. PMID 9464732. S2CID 43765652.
Berardi A, Rossi C, Biasini A, Minniti S, Venturelli C, Ferrari F, Facchinetti F (April 2011). "Efficacy of intrapartum chemoprophylaxis less than 4 hours duration". The Journal of Maternal-Fetal & Neonatal Medicine. 24 (4): 619–625. doi:10.3109/14767058.2010.511347. PMID 20828241. S2CID 6697604.
"Prevention of Early-onset Neonatal Group B Streptococcal Disease: Green-top Guideline No. 36". BJOG. 124 (12): e280 – e305. November 2017. doi:10.1111/1471-0528.14821. PMID 28901693. S2CID 32700635.
Desai SH, Kaplan MS, Chen Q, Macy EM (2017). "Morbidity in Pregnant Women Associated with Unverified Penicillin Allergies, Antibiotic Use, and Group B Streptococcus Infections". The Permanente Journal. 21: 16–080. doi:10.7812/TPP/16-080. PMC 5363897. PMID 28333608.
Bhattacharya S (January 2010). "The facts about penicillin allergy: a review". Journal of Advanced Pharmaceutical Technology & Research. 1 (1): 11–17. doi:10.4103/2231-4040.70513. PMC 3255391. PMID 22247826.
Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL (November 2001). "Early-onset neonatal sepsis in the era of group B streptococcal prevention". Pediatrics. 108 (5): 1094–1098. doi:10.1542/peds.108.5.1094. PMID 11694686.
Sutkin G, Krohn MA, Heine RP, Sweet RL (March 2005). "Antibiotic prophylaxis and non-group B streptococcal neonatal sepsis". Obstetrics and Gynecology. 105 (3): 581–586. doi:10.1097/01.aog.0000153492.30757.2f. PMID 15738028. S2CID 22019440.
Schrag SJ, Hadler JL, Arnold KE, Martell-Cleary P, Reingold A, Schuchat A (August 2006). "Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use". Pediatrics. 118 (2): 570–576. doi:10.1542/peds.2005-3083. PMID 16882809. S2CID 34908773.
Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, et al. (December 2009). "Chlorhexidine maternal-vagina, and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial". Lancet. 374 (9705): 1909–1916. doi:10.1016/S0140-6736(09)61339-8. PMID 19846212. S2CID 23418670.
Ohlsson A, Shah VS, Stade BC (December 2014). "Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection". The Cochrane Database of Systematic Reviews. 12 (12): CD003520. doi:10.1002/14651858.CD003520.pub3. PMC 11262555. PMID 25504106.
Clifford V, Garland SM, Grimwood K (September 2012). "Prevention of neonatal group B streptococcus disease in the 21st century". Journal of Paediatrics and Child Health. 48 (9): 808–815. doi:10.1111/j.1440-1754.2011.02203.x. PMID 22151082. S2CID 36906520.
Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. (July 2002). "A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates". The New England Journal of Medicine. 347 (4): 233–239. doi:10.1056/nejmoa020205. PMID 12140298.
Giménez M, Sanfeliu I, Sierra M, et al. (2015). "[Group B streptococcal early-onset neonatal sepsis in the area of Barcelona (2004-2010). Analysis of missed opportunities for prevention]". Enfermedades Infecciosas y Microbiologia Clinica. 33 (7): 446–450. doi:10.1016/j.eimc.2014.10.015. PMID 25541009. S2CID 196362631.
Håkansson S, Axemo P, Bremme K, et al. (January 2008). "Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation". Acta Obstetricia et Gynecologica Scandinavica. 87 (1): 50–58. doi:10.1080/00016340701802888. PMID 18158627. S2CID 38090766.
Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. (May 2008). "Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005". JAMA. 299 (17): 2056–2065. doi:10.1001/jama.299.17.2056. PMID 18460666.
Le Doare K, O'Driscoll M, Turner K, Seedat F (2017). "Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review". Clin Infect Dis. 65 (Suppl 2): s143-151. doi:10.1093/cid/cix654. PMC 5850619. PMID 29117324.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Colbourn T, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, Gilbert RE (August 2007). "Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses". Health Technology Assessment. 11 (29): 1–226, iii. doi:10.3310/hta11290. PMID 17651659.
Colbourn TE, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, et al. (September 2007). "Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses" (PDF). BMJ. 335 (7621): 655. doi:10.1136/bmj.39325.681806.AD. PMC 1995477. PMID 17848402.
Kaambwa B, Bryan S, Gray J, Milner P, Daniels J, Khan KS, Roberts TE (December 2010). "Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour". BJOG. 117 (13): 1616–1627. doi:10.1111/j.1471-0528.2010.02752.x. PMID 21078057. S2CID 25561127.
Vergnano S, Embleton N, Collinson A, Menson E, Russell AB, Heath P (January 2010). "Missed opportunities for preventing group B streptococcus infection". Archives of Disease in Childhood. Fetal and Neonatal Edition. 95 (1): F72 – F73. doi:10.1136/adc.2009.160333. PMID 19439431. S2CID 38297857.
Steer PJ, Plumb J (October 2011). "Myth: Group B streptococcal infection in pregnancy: comprehended and conquered". Seminars in Fetal & Neonatal Medicine. 16 (5): 254–258. doi:10.1016/j.siny.2011.03.005. PMID 21493170.
Siegel JD, Cushion NB (May 1996). "Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth". Obstetrics and Gynecology. 87 (5 Pt 1): 692–698. doi:10.1016/0029-7844(96)00004-x. PMID 8677068. S2CID 40716699.
Velaphi S, Siegel JD, Wendel GD, Cushion N, Eid WM, Sánchez PJ (March 2003). "Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy". Pediatrics. 111 (3): 541–547. doi:10.1542/peds.111.3.541. PMID 12612234.
Woodgate P, Flenady V, Steer P (2004). "Intramuscular penicillin for the prevention of early onset group B streptococcal infection in newborn infants". The Cochrane Database of Systematic Reviews. 2004 (3): CD003667. doi:10.1002/14651858.CD003667.pub2. PMC 9029842. PMID 15266494.
Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR (November 1996). "The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery". Obstetrics and Gynecology. 88 (5): 811–815. doi:10.1016/0029-7844(96)00320-1. PMID 8885919.
Valkenburg-van den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, Dekker FW, Dörr PJ, Sprij AJ (2010). "Timing of group B streptococcus screening in pregnancy: a systematic review". Gynecologic and Obstetric Investigation. 69 (3): 174–183. doi:10.1159/000265942. PMID 20016190. S2CID 26709882.
Price D, Shaw E, Howard M, Zazulak J, Waters H, Kaczorowski J (December 2006). "Self-sampling for group B streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable: a randomized cross-over trial". Journal of Obstetrics and Gynaecology Canada. 28 (12): 1083–1088. doi:10.1016/s1701-2163(16)32337-4. PMID 17169231.
Hicks P, Diaz-Perez MJ (2009). "Patient self-collection of group B streptococcal specimens during pregnancy" (PDF). Journal of the American Board of Family Medicine. 22 (2): 136–140. doi:10.3122/jabfm.2009.02.080011. PMID 19264936. S2CID 2208746.
Arya A, Cryan B, O'Sullivan K, Greene RA, Higgins JR (July 2008). "Self-collected versus health professional-collected genital swabs to identify the prevalence of group B streptococcus: a comparison of patient preference and efficacy". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 139 (1): 43–45. doi:10.1016/j.ejogrb.2007.12.005. PMID 18255214.
Odubamowo K, Garcia M, Muriithi F, Ogollah R, Daniels JP, Walker KF (2023). "Self-collected versus health-care professional taken swab for identification of vaginal-rectal colonisation with group B streptococcus in late pregnancy: a systematic review". Eur J Obstet Gynecol Reprod Biol. 286: 95–101. doi:10.1016/j.ejogrb.2023.05.027. PMID 37229964. S2CID 258860996. Retrieved 27 November 2023.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Rosa-Fraile M, Camacho-Muñoz E, Rodríguez-Granger J, Liébana-Martos C (February 2005). "Specimen storage in transport medium and detection of group B streptococci by culture". Journal of Clinical Microbiology. 43 (2): 928–930. doi:10.1128/jcm.43.2.928-930.2005. PMC 548104. PMID 15695709.
Gil EG, Rodríguez MC, Bartolomé R, Berjano B, Cabero L, Andreu A (August 1999). "Evaluation of the Granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women". Journal of Clinical Microbiology. 37 (8): 2648–2651. doi:10.1128/JCM.37.8.2648-2651.1999. PMC 85303. PMID 10405415.
Claeys G, Verschraegen G, Temmerman M (January 2001). "Modified Granada Agar Medium for the detection of group B Streptococcus carriage in pregnant women". Clinical Microbiology and Infection. 7 (1): 22–24. doi:10.1046/j.1469-0691.2001.00156.x. PMID 11284939.
Buchan BW, Faron ML, Fuller D, Davis TE, Mayne D, Ledeboer NA (February 2015). "Multicenter clinical evaluation of the Xpert GBS LB assay for detection of group B Streptococcus in prenatal screening specimens". Journal of Clinical Microbiology. 53 (2): 443–448. doi:10.1128/jcm.02598-14. PMC 4298547. PMID 25411176.
Koliwer-Brandl H, Nil A, Birri J, Sachs M, Zimmermann R, Zbinden R, Balsyte D (2023). "Evaluation of two rapid commercial assays for detection of Streptococcus agalactiae from vaginal samples". Acta Obstet Gynecol Scand. 102 (4): 450–456. doi:10.1111/aogs.14519. PMC 10008276. PMID 36772902.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Daniels J, Gray J, Pattison H, Roberts T, Edwards E, Milner P, et al. (September 2009). "Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness". Health Technology Assessment. 13 (42): 1–154, iii–iv. doi:10.3310/hta13420. PMID 19778493.
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (September 2019). "Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 322 (12): 1188–1194. doi:10.1001/jama.2019.13069. PMID 31550038. S2CID 202746652.
Smaill, Fiona M.; Vazquez, Juan C. (25 November 2019). "Antibiotics for asymptomatic bacteriuria in pregnancy". The Cochrane Database of Systematic Reviews. 2019 (11): CD000490. doi:10.1002/14651858.CD000490.pub4. PMC 6953361. PMID 31765489.
Pulver LS, Hopfenbeck MM, Young PC, Stoddard GJ, Korgenski K, Daly J, Byington CL (January 2009). "Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis". Journal of Perinatology. 29 (1): 20–25. doi:10.1038/jp.2008.115. PMID 18704032.
Melin P (September 2011). "Neonatal group B streptococcal disease: from pathogenesis to preventive strategies". Clinical Microbiology and Infection. 17 (9): 1294–1303. doi:10.1111/j.1469-0691.2011.03576.x. PMID 21672083.
Berardi A, Lugli L, Baronciani D, Rossi C, Ciccia M, Creti R, et al. (February 2010). "Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach". The Pediatric Infectious Disease Journal. 29 (2): 115–121. doi:10.1097/inf.0b013e3181b83cd9. PMID 19915512. S2CID 31548613.
Schrag SJ, Verani JR (August 2013). "Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine". Vaccine. 31 (Suppl 4): D20 – D26. doi:10.1016/j.vaccine.2012.11.056. PMC 11843781. PMID 23219695.
Gillen P, Bamidele O, Healy M. (2023). "Systematic review of women's experiences of planning home birth in consultation with maternity care providers in middle to high-income countries". Midwifery. 124. doi:10.1016/j.midw.2023.103733. PMID 37307778. Retrieved 3 July 2024.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Whittington JR, Ghahremani T, Whitham M, Phillips AM, Spracher BN, Magann EF. (2023). "Alternate Birth Strategies". Int J Womens Health. 15: 1151–1159. doi:10.2147/IJWH.S405533. PMC 10368118. PMID 37496517.{{cite journal}}: CS1 maint: multiple names: authors list (link)
"Prevention of Early-onset Neonatal Group B Streptococcal Disease: Green-top Guideline No. 36". BJOG. 124 (12): e280 – e305. November 2017. doi:10.1111/1471-0528.14821. PMID 28901693. S2CID 32700635.
Gonçalves BP, Procter SR, Paul P, Chandna J, Lewin A. (2022). "Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden". Lancet Glob Health. 10 (6): e807 – e819. doi:10.1016/S2214-109X(22)00093-6. PMC 9090904. PMID 35490693.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Proma P., Goncalvez B.P., Le Doare k., Lawn E. (2023). "20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention". Curr Opin Pediatr. 35 (2): 223–230. doi:10.1097/MOP.0000000000001223. PMC 9994794. PMID 36749143.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. (January 2004). "Group B streptococcal disease in UK and Irish infants younger than 90 days". Lancet. 363 (9405): 292–294. doi:10.1016/s0140-6736(03)15389-5. PMID 14751704. S2CID 22371160.
Le Doare K, Heath PT (August 2013). "An overview of global GBS epidemiology". Vaccine. 31 (Suppl 4): D7-12. doi:10.1016/j.vaccine.2013.01.009. PMID 23973349.
Brigtsen AK, Jacobsen AF, Dedi L, Melby KK, Fugelseth D, Whitelaw A (2015). "Maternal Colonization with Group B Streptococcus Is Associated with an Increased Rate of Infants Transferred to the Neonatal Intensive Care Unit". Neonatology. 108 (3): 157–163. doi:10.1159/000434716. PMID 26182960. S2CID 24711146.
Carbonell-Estrany X, Figueras-Aloy J, Salcedo-Abizanda S, de la Rosa-Fraile M (March 2008). "Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection". Archives of Disease in Childhood. Fetal and Neonatal Edition. 93 (2): F85 – F89. doi:10.1136/adc.2007.119958. PMID 17704105. S2CID 10300571.
Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, Breathnach A, Russell AB (June 2003). "Estimated early-onset group B streptococcal neonatal disease". Lancet. 361 (9373): 1953–1954. doi:10.1016/S0140-6736(03)13553-2. PMID 12801740. S2CID 33025300.
Lamagni TL, Keshishian C, Efstratiou A, Guy R, Henderson KL, Broughton K, Sheridan E (September 2013). "Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010". Clinical Infectious Diseases. 57 (5): 682–688. doi:10.1093/cid/cit337. PMID 23845950.
Baker CJ (August 2013). "The spectrum of perinatal group B streptococcal disease". Vaccine. 31 (Suppl 4): D3 – D6. doi:10.1016/j.vaccine.2013.02.030. PMID 23973344.
Andreu A, Sanfeliu I, Viñas L, Barranco M, Bosch J, Dopico E, et al. (April 2003). "[Decreasing incidence of perinatal group B streptococcal disease (Barcelona 1994-2002). Relation with hospital prevention policies]". Enfermedades Infecciosas y Microbiologia Clinica. 21 (4): 174–179. doi:10.1016/s0213-005x(03)72913-9. PMID 12681128.
Rosa-Fraile M, Alós JI. (2022). "Group B Streptococcus neonatal infections, the ongoing history". Enferm Infecc Microbiol Clin. 40 (7): 349–352. doi:10.1016/j.eimce.2022.01.002. PMID 35906029.
Albouy-Llaty M, Nadeau C, Descombes E, Pierre F, Migeot V (August 2012). "Improving perinatal Group B streptococcus screening with process indicators". Journal of Evaluation in Clinical Practice. 18 (4): 727–733. doi:10.1111/j.1365-2753.2011.01658.x. PMID 21414110.
Sikias P, Biran V, Foix-L'Hélias L, Plainvert C, Boileau P, Bonacorsi S; EOS study group. (2022). "Early-onset neonatal sepsis in the Paris area: a population-based surveillance study from 2019 to 2021". Arch Dis Child Fetal Neonatal. 108 (2): 114–120. doi:10.1136/archdischild-2022-324080. PMC 9985718. PMID 35902218.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Raabe VN, Shane AL (March 2019). "Group B Streptococcus (Streptococcus agalactiae)". Microbiology Spectrum. 7 (2). doi:10.1128/microbiolspec.GPP3-0007-2018. PMC 6432937. PMID 30900541.
Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, et al. (November 2017). "Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children". Clinical Infectious Diseases. 65 (suppl_2): S200 – S219. doi:10.1093/cid/cix664. PMC 5849940. PMID 29117332.
Benitz WE, Gould JB, Druzin ML (June 1999). "Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review". Pediatrics. 103 (6): e77. doi:10.1542/peds.103.6.e77. PMID 10353974.
Couturier BA, Weight T, Elmer H, Schlaberg R (September 2014). Carroll KC (ed.). "Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates". Journal of Clinical Microbiology. 52 (9): 3429–3432. doi:10.1128/JCM.01081-14. PMC 4313176. PMID 25009049.
Money D, Allen VM (August 2018). "N^o 298 - Prévention de l'infection néonatale à streptocoques du groupe B d'apparition précoce". Journal of Obstetrics and Gynaecology Canada. 40 (8): e675 – e686. doi:10.1016/j.jogc.2018.05.033. PMID 30103892. S2CID 51980587.
Alós Cortés JI, Andreu Domingo A, Arribas Mir L, Cabero Roura L, Cueto Lopez M, López Sastre J, et al. (March 2012). "[Prevention of perinatal group B Streptococcal disease. Updated Spanish recommendations 2012]" (PDF). Revista Espanola de Quimioterapia. 25 (1): 79–88. PMID 22488547. Retrieved 25 November 2019.
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe (2007). "[Prevention of neonatal infection with Streptococcus Group B. Expert correspondence no. 19 of 29th December 2006]". Gynäkologisch-geburtshilfliche Rundschau. 47 (2): 103–104. doi:10.1159/000100342. PMID 17440274. S2CID 77887846.
Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, et al. (July 2009). "Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007". Clinical Infectious Diseases. 49 (1): 85–92. doi:10.1086/599369. PMID 19480572.
Farley MM (August 2001). "Group B streptococcal disease in nonpregnant adults". Clinical Infectious Diseases. 33 (4): 556–561. doi:10.1086/322696. PMID 11462195.
Edwards MS, Baker CJ (September 2005). "Group B streptococcal infections in elderly adults". Clinical Infectious Diseases. 41 (6): 839–847. doi:10.1086/432804. PMID 16107984.
Collin SM, Shetty N, Lamagni T. (2020). "Invasive Group B Streptococcus Infections in Adults, England, 2015-2016". Emerg Infect Dis. 26 (6): 1174–1181. doi:10.3201/eid2606.191141. PMC 7258460. PMID 32441619.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Graux E, Hites M, Martiny D, Maillart E, Delforge M, Melin P, Dauby N (March 2021). "Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005-2019". European Journal of Clinical Microbiology & Infectious Diseases. 40 (3): 515–523. doi:10.1007/s10096-020-04041-0. PMC 7498195. PMID 32944894.
Al Akhrass F, Abdallah L, Berger S, Hanna R, Reynolds N, Thompson S, et al. (January 2013). "Streptococcus agalactiae toxic shock-like syndrome: two case reports and review of the literature". Medicine. 92 (1): 10–14. doi:10.1097/MD.0b013e31827dea11. PMC 5370747. PMID 23263717.
Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. (December 2008). "Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis". The Pediatric Infectious Disease Journal. 27 (12): 1057–1064. doi:10.1097/inf.0b013e318180b3b9. PMID 18989238. S2CID 1533957.
Edwards MS, Rench MA, Rinaudo CD, Fabbrini M, Tuscano G, Buffi G, et al. (November 2016). "Immune Responses to Invasive Group B Streptococcal Disease in Adults". Emerging Infectious Diseases. 22 (11): 1877–1883. doi:10.3201/eid2211.160914. PMC 5088039. PMID 27767008.
Procter SR, Gonçalves BP, Paul P, Chandna J, Seedat F, Koukounari A, Hutubessy R, Trotter C, Lawn JE, Jit M. (2023). "Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness". PLOS Med. 20 (3): e1004068. doi:10.1371/journal.pmed.1004068. PMC 10013922. PMID 36917564.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Baker CJ, Carey VJ, Rench MA, Edwards MS, Hillier SL, Kasper DL, Platt R (March 2014). "Maternal antibody at delivery protects neonates from early onset group B streptococcal disease". The Journal of Infectious Diseases. 209 (5): 781–788. doi:10.1093/infdis/jit549. PMC 3923540. PMID 24133184.
Madhi SA, Cutland CL, Jose L, Koen A, Govender N, Wittke F, et al. (August 2016). "Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial". The Lancet. Infectious Diseases. 16 (8): 923–934. doi:10.1016/S1473-3099(16)00152-3. PMID 27139805.
Edwards MS, Gonik B (August 2013). "Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination". Vaccine. 31 (Suppl 4): D66 – D71. doi:10.1016/j.vaccine.2012.11.046. PMID 23200934.
Heath PT (June 2016). "Status of vaccine research and development of vaccines for GBS". Vaccine. 34 (26): 2876–2879. doi:10.1016/j.vaccine.2015.12.072. PMID 26988258.
Song JY, Lim JH, Lim S, Yong Z, Seo HS (2018). "Progress toward a group B streptococcal vaccine". Human Vaccines & Immunotherapeutics. 14 (11): 2669–2681. doi:10.1080/21645515.2018.1493326. PMC 6314413. PMID 29995578.
Gupalova T, Leontieva G, Kramskaya T, Grabovskaya K, Bormotova E, Korjevski D, Suvorov A (2018). "Development of experimental GBS vaccine for mucosal immunization". PLOS ONE. 13 (5): e0196564. Bibcode:2018PLoSO..1396564G. doi:10.1371/journal.pone.0196564. PMC 5935385. PMID 29727446.
Carreras-Abad C, Ramkhelawon L, Heath PT, Le Doare K (2020). "A Vaccine Against Group B Streptococcus: Recent Advances". Infection and Drug Resistance. 13: 1263–1272. doi:10.2147/IDR.S203454. PMC 7196769. PMID 32425562. Retrieved 26 November 2023.
Dominguez K, Randis TM. (2022). "Toward the development of a protein-based group B Streptococcus vaccine". Cell Rep Med. 3 (2): 10.1016/j.xcrm.2022.100536. doi:10.1016/j.xcrm.2022.100536. PMC 8861943. PMID 35243427.
Nuccitelli A, Rinaudo CD, Maione D (May 2015). "Group B Streptococcus vaccine: state of the art". Therapeutic Advances in Vaccines. 3 (3): 76–90. doi:10.1177/2051013615579869. PMC 4530403. PMID 26288735.
Davies HG, Carreras-Abad C, Le Doare K, Heath PT (June 2019). "Group B Streptococcus: Trials and Tribulations". The Pediatric Infectious Disease Journal. 38 (6S Suppl 1): S72 – S76. doi:10.1097/INF.0000000000002328. PMID 31205250. S2CID 189943251. Retrieved 26 November 2023.
Madhi SA (June 2023). "Potential for Maternally Administered Vaccines for Infant Group B Streptococcus". New England Journal of Medicine. 389 (3): 215–227. doi:10.1056/NEJMoa2116045. hdl:2263/94684. PMID 37467497. S2CID 259995252.
Absalon J, Simon R, Radley D, Giardina PC, Koury K, Jansen KU, Anderson AS. (2022). "Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches". Hum Vaccin Immunother. 18 (1): 2037350. doi:10.1080/21645515.2022.2037350. PMC 9009955. PMID 35240933.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Trotter CL, Alderson M, Dangor Z, Ip M, Le Doare K, Nakabembe E, Procter SR, Sekikubo M, Lambach P. (2023). "Vaccine value profile for Group B streptococcus". Vaccine. 41: Suppl 2:S41-S52. doi:10.1016/j.vaccine.2023.04.024. PMID 37951694. Retrieved 7 July 2024.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Buurman ET (June 2019). "A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization". J Infect Dis. 220 (1): 105–115. doi:10.1093/infdis/jiz062. PMC 6548902. PMID 30778554.
Delannoy CM, Crumlish M, Fontaine MC, Pollock J, Foster G, Dagleish MP, et al. (February 2013). "Human Streptococcus agalactiae strains in aquatic mammals and fish". BMC Microbiology. 13: 41. doi:10.1186/1471-2180-13-41. PMC 3585737. PMID 23419028.
Keefe GP (July 1997). "Streptococcus agalactiae mastitis: a review". The Canadian Veterinary Journal. 38 (7): 429–437. PMC 1576741. PMID 9220132.
Cheng WN, Han SG. (2020). "Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments - A review". Asian-Australasian Journal of Animal Science. 33 (11): 1699–1713. doi:10.5713/ajas.20.0156. PMC 7649072. PMID 32777908.
Ruegg PL (December 2017). "A 100-Year Review: Mastitis detection, management, and prevention". Journal of Dairy Science. 100 (12): 10381–10397. doi:10.3168/jds.2017-13023. PMID 29153171. S2CID 6122209. Retrieved 26 November 2023.
Morales-Ubaldo AL, Rivero-Perez N, Valladares-Carranza B, Velázquez-Ordoñez V, Delgadillo-Ruiz L, Zaragoza-Bastida A. (2023). "Bovine mastitis, a worldwide impact disease: Prevalence, antimicrobial resistance, and viable alternative approaches". Vet Anim Sci. 21: 100306. doi:10.1016/j.vas.2023.100306. PMC 10400929. PMID 37547227.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Crestani C, Forde TL, Lycett SJ, Holmes MA, Fasth C, Persson-Waller K, Zadoks RN. (2021). "The fall and rise of group B Streptococcus in dairy cattle: reintroduction due to human-to- cattle host jumps?". Microbial Genomics. 7 (9): 000648. doi:10.1099/mgen.0.000648. PMC 8715428. PMID 34486971.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Evans JJ, Klesius PH, Pasnik DJ, Bohnsack JF (May 2009). "Human Streptococcus agalactiae isolate in Nile tilapia (Oreochromis niloticus)". Emerging Infectious Diseases. 15 (5): 774–776. doi:10.3201/eid1505.080222. PMC 2687030. PMID 19402966.
Liu G, Zhang W, Lu C (November 2013). "Comparative genomics analysis of Streptococcus agalactiae reveals that isolates from cultured tilapia in China are closely related to the human strain A909". BMC Genomics. 14: 775. doi:10.1186/1471-2164-14-775. PMC 3831827. PMID 24215651.
Li LP, Wang R, Liang WW, Huang T, Huang Y, Luo FG, et al. (August 2015). "Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro". Fish & Shellfish Immunology. 45 (2): 955–963. Bibcode:2015FSI....45..955L. doi:10.1016/j.fsi.2015.06.014. PMID 26087276.
Zhang D, Gao Y, Li Q, Ke X, Liu Z, Lu M, Shi C (March 2020). "An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus)". Fish & Shellfish Immunology. 98: 853–859. Bibcode:2020FSI....98..853Z. doi:10.1016/j.fsi.2019.11.044. PMID 31751658. S2CID 208226408.
Thompson KD, Rodkhum C, Bunnoy A, Thangsunan P, Kitiyodom S, Sukkarun Yostawornkul J, Yata T, Pirarat N. (2023). "Addressing Nanovaccine Strategies for Tilapia". Vaccines. 11 (8): 1356. doi:10.3390/vaccines11081356. PMC 10459980. PMID 37631924.{{cite journal}}: CS1 maint: multiple names: authors list (link)

ncbi.nlm.nih.gov

Rosa-Fraile M, Spellerberg B (September 2017). "Reliable Detection of Group B Streptococcus in the Clinical Laboratory". Journal of Clinical Microbiology. 55 (9): 2590–2598. doi:10.1128/JCM.00582-17. PMC 5648696. PMID 28659318.
Filkins L, Hauser JR, Robinson-Dunn B, Tibbetts R, Boyanton BL, Revell P (December 2020). "American Society for Microbiology Provides 2020 Guidelines for Detection and Identification of Group B Streptococcus". Journal of Clinical Microbiology. 59 (1). doi:10.1128/JCM.01230-20. PMC 7771461. PMID 33115849.
Rosa-Fraile M, Rodriguez-Granger J, Cueto-Lopez M, Sampedro A, Gaye EB, Haro JM, Andreu A (August 1999). "Use of Granada medium to detect group B streptococcal colonization in pregnant women". Journal of Clinical Microbiology. 37 (8): 2674–2677. doi:10.1128/JCM.37.8.2674-2677.1999. PMC 85311. PMID 10405420.
To KN, Cornwell E, Daniel R, Goonesekera S, Jauneikaite E, Chalker V, Le Doare K (February 2019). "Evaluation of matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) for the Identification of Group B Streptococcus". BMC Research Notes. 12 (1): 85. doi:10.1186/s13104-019-4119-1. PMC 6376729. PMID 30764872.
El Aila NA, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H, et al. (September 2010). "Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women". BMC Infectious Diseases. 10: 285. doi:10.1186/1471-2334-10-285. PMC 2956727. PMID 20920213.
Roloff K, Stepanyan G , Valenzuela G (2018). "Prevalence of oropharyngeal group B Streptococcus colonization in mothers, family, and health care providers". PLOS ONE. 13 (9): e0204617. Bibcode:2018PLoSO..1304617R. doi:10.1371/journal.pone.0204617. PMC 6161895. PMID 30265687.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Russell NJ, Seale AC, O'Driscoll M, O'Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al. (November 2017). "Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses". Clinical Infectious Diseases. 65 (suppl_2): S100 – S111. doi:10.1093/cid/cix658. PMC 5848259. PMID 29117327.
Raabe, Vanessa N.; Shane, Andi L. (March 2019). "Group B Streptococcus (Streptococcus agalactiae)". Microbiology Spectrum. 7 (2): 10.1128/microbiolspec.GPP3–0007–2018. doi:10.1128/microbiolspec.GPP3-0007-2018. ISSN 2165-0497. PMC 6432937. PMID 30900541.
Russell NJ, Seale AC, O'Sullivan C, Le Doare K, Heath PT, Lawn JE, et al. (November 2017). "Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses". Clinical Infectious Diseases. 65 (suppl_2): S152 – S159. doi:10.1093/cid/cix655. PMC 5850448. PMID 29117325.
Dauby N, Chamekh M, Melin P, Slogrove AL, Goetghebuer T (2016). "Increased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible Mechanisms". Frontiers in Immunology. 7: 505. doi:10.3389/fimmu.2016.00505. PMC 5110531. PMID 27899925.
Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, et al. (March 2019). "Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance". JAMA Pediatrics. 173 (3): 224–233. doi:10.1001/jamapediatrics.2018.4826. PMC 6439883. PMID 30640366.
Karampatsas K, Davies H, Mynarek M, Andrews N, Heath PT, Le Doare K. (2022). "Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-Analyses". Clin Infect Dis. 75 (7): 1255–1264. doi:10.1093/cid/ciac206. PMC 9525091. PMID 35275986.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Desai SH, Kaplan MS, Chen Q, Macy EM (2017). "Morbidity in Pregnant Women Associated with Unverified Penicillin Allergies, Antibiotic Use, and Group B Streptococcus Infections". The Permanente Journal. 21: 16–080. doi:10.7812/TPP/16-080. PMC 5363897. PMID 28333608.
Bhattacharya S (January 2010). "The facts about penicillin allergy: a review". Journal of Advanced Pharmaceutical Technology & Research. 1 (1): 11–17. doi:10.4103/2231-4040.70513. PMC 3255391. PMID 22247826.
Ohlsson A, Shah VS, Stade BC (December 2014). "Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection". The Cochrane Database of Systematic Reviews. 12 (12): CD003520. doi:10.1002/14651858.CD003520.pub3. PMC 11262555. PMID 25504106.
Le Doare K, O'Driscoll M, Turner K, Seedat F (2017). "Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review". Clin Infect Dis. 65 (Suppl 2): s143-151. doi:10.1093/cid/cix654. PMC 5850619. PMID 29117324.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Colbourn TE, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, et al. (September 2007). "Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses" (PDF). BMJ. 335 (7621): 655. doi:10.1136/bmj.39325.681806.AD. PMC 1995477. PMID 17848402.
Woodgate P, Flenady V, Steer P (2004). "Intramuscular penicillin for the prevention of early onset group B streptococcal infection in newborn infants". The Cochrane Database of Systematic Reviews. 2004 (3): CD003667. doi:10.1002/14651858.CD003667.pub2. PMC 9029842. PMID 15266494.
Rosa-Fraile M, Camacho-Muñoz E, Rodríguez-Granger J, Liébana-Martos C (February 2005). "Specimen storage in transport medium and detection of group B streptococci by culture". Journal of Clinical Microbiology. 43 (2): 928–930. doi:10.1128/jcm.43.2.928-930.2005. PMC 548104. PMID 15695709.
Gil EG, Rodríguez MC, Bartolomé R, Berjano B, Cabero L, Andreu A (August 1999). "Evaluation of the Granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women". Journal of Clinical Microbiology. 37 (8): 2648–2651. doi:10.1128/JCM.37.8.2648-2651.1999. PMC 85303. PMID 10405415.
Buchan BW, Faron ML, Fuller D, Davis TE, Mayne D, Ledeboer NA (February 2015). "Multicenter clinical evaluation of the Xpert GBS LB assay for detection of group B Streptococcus in prenatal screening specimens". Journal of Clinical Microbiology. 53 (2): 443–448. doi:10.1128/jcm.02598-14. PMC 4298547. PMID 25411176.
Koliwer-Brandl H, Nil A, Birri J, Sachs M, Zimmermann R, Zbinden R, Balsyte D (2023). "Evaluation of two rapid commercial assays for detection of Streptococcus agalactiae from vaginal samples". Acta Obstet Gynecol Scand. 102 (4): 450–456. doi:10.1111/aogs.14519. PMC 10008276. PMID 36772902.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Smaill, Fiona M.; Vazquez, Juan C. (25 November 2019). "Antibiotics for asymptomatic bacteriuria in pregnancy". The Cochrane Database of Systematic Reviews. 2019 (11): CD000490. doi:10.1002/14651858.CD000490.pub4. PMC 6953361. PMID 31765489.
Schrag SJ, Verani JR (August 2013). "Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine". Vaccine. 31 (Suppl 4): D20 – D26. doi:10.1016/j.vaccine.2012.11.056. PMC 11843781. PMID 23219695.
Whittington JR, Ghahremani T, Whitham M, Phillips AM, Spracher BN, Magann EF. (2023). "Alternate Birth Strategies". Int J Womens Health. 15: 1151–1159. doi:10.2147/IJWH.S405533. PMC 10368118. PMID 37496517.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Gonçalves BP, Procter SR, Paul P, Chandna J, Lewin A. (2022). "Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden". Lancet Glob Health. 10 (6): e807 – e819. doi:10.1016/S2214-109X(22)00093-6. PMC 9090904. PMID 35490693.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Proma P., Goncalvez B.P., Le Doare k., Lawn E. (2023). "20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention". Curr Opin Pediatr. 35 (2): 223–230. doi:10.1097/MOP.0000000000001223. PMC 9994794. PMID 36749143.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Sikias P, Biran V, Foix-L'Hélias L, Plainvert C, Boileau P, Bonacorsi S; EOS study group. (2022). "Early-onset neonatal sepsis in the Paris area: a population-based surveillance study from 2019 to 2021". Arch Dis Child Fetal Neonatal. 108 (2): 114–120. doi:10.1136/archdischild-2022-324080. PMC 9985718. PMID 35902218.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Raabe VN, Shane AL (March 2019). "Group B Streptococcus (Streptococcus agalactiae)". Microbiology Spectrum. 7 (2). doi:10.1128/microbiolspec.GPP3-0007-2018. PMC 6432937. PMID 30900541.
Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, et al. (November 2017). "Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children". Clinical Infectious Diseases. 65 (suppl_2): S200 – S219. doi:10.1093/cid/cix664. PMC 5849940. PMID 29117332.
Couturier BA, Weight T, Elmer H, Schlaberg R (September 2014). Carroll KC (ed.). "Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates". Journal of Clinical Microbiology. 52 (9): 3429–3432. doi:10.1128/JCM.01081-14. PMC 4313176. PMID 25009049.
Collin SM, Shetty N, Lamagni T. (2020). "Invasive Group B Streptococcus Infections in Adults, England, 2015-2016". Emerg Infect Dis. 26 (6): 1174–1181. doi:10.3201/eid2606.191141. PMC 7258460. PMID 32441619.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Graux E, Hites M, Martiny D, Maillart E, Delforge M, Melin P, Dauby N (March 2021). "Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005-2019". European Journal of Clinical Microbiology & Infectious Diseases. 40 (3): 515–523. doi:10.1007/s10096-020-04041-0. PMC 7498195. PMID 32944894.
Al Akhrass F, Abdallah L, Berger S, Hanna R, Reynolds N, Thompson S, et al. (January 2013). "Streptococcus agalactiae toxic shock-like syndrome: two case reports and review of the literature". Medicine. 92 (1): 10–14. doi:10.1097/MD.0b013e31827dea11. PMC 5370747. PMID 23263717.
Edwards MS, Rench MA, Rinaudo CD, Fabbrini M, Tuscano G, Buffi G, et al. (November 2016). "Immune Responses to Invasive Group B Streptococcal Disease in Adults". Emerging Infectious Diseases. 22 (11): 1877–1883. doi:10.3201/eid2211.160914. PMC 5088039. PMID 27767008.
Procter SR, Gonçalves BP, Paul P, Chandna J, Seedat F, Koukounari A, Hutubessy R, Trotter C, Lawn JE, Jit M. (2023). "Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness". PLOS Med. 20 (3): e1004068. doi:10.1371/journal.pmed.1004068. PMC 10013922. PMID 36917564.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Baker CJ, Carey VJ, Rench MA, Edwards MS, Hillier SL, Kasper DL, Platt R (March 2014). "Maternal antibody at delivery protects neonates from early onset group B streptococcal disease". The Journal of Infectious Diseases. 209 (5): 781–788. doi:10.1093/infdis/jit549. PMC 3923540. PMID 24133184.
Song JY, Lim JH, Lim S, Yong Z, Seo HS (2018). "Progress toward a group B streptococcal vaccine". Human Vaccines & Immunotherapeutics. 14 (11): 2669–2681. doi:10.1080/21645515.2018.1493326. PMC 6314413. PMID 29995578.
Gupalova T, Leontieva G, Kramskaya T, Grabovskaya K, Bormotova E, Korjevski D, Suvorov A (2018). "Development of experimental GBS vaccine for mucosal immunization". PLOS ONE. 13 (5): e0196564. Bibcode:2018PLoSO..1396564G. doi:10.1371/journal.pone.0196564. PMC 5935385. PMID 29727446.
Carreras-Abad C, Ramkhelawon L, Heath PT, Le Doare K (2020). "A Vaccine Against Group B Streptococcus: Recent Advances". Infection and Drug Resistance. 13: 1263–1272. doi:10.2147/IDR.S203454. PMC 7196769. PMID 32425562. Retrieved 26 November 2023.
Dominguez K, Randis TM. (2022). "Toward the development of a protein-based group B Streptococcus vaccine". Cell Rep Med. 3 (2): 10.1016/j.xcrm.2022.100536. doi:10.1016/j.xcrm.2022.100536. PMC 8861943. PMID 35243427.
Nuccitelli A, Rinaudo CD, Maione D (May 2015). "Group B Streptococcus vaccine: state of the art". Therapeutic Advances in Vaccines. 3 (3): 76–90. doi:10.1177/2051013615579869. PMC 4530403. PMID 26288735.
Absalon J, Simon R, Radley D, Giardina PC, Koury K, Jansen KU, Anderson AS. (2022). "Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches". Hum Vaccin Immunother. 18 (1): 2037350. doi:10.1080/21645515.2022.2037350. PMC 9009955. PMID 35240933.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Buurman ET (June 2019). "A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization". J Infect Dis. 220 (1): 105–115. doi:10.1093/infdis/jiz062. PMC 6548902. PMID 30778554.
Delannoy CM, Crumlish M, Fontaine MC, Pollock J, Foster G, Dagleish MP, et al. (February 2013). "Human Streptococcus agalactiae strains in aquatic mammals and fish". BMC Microbiology. 13: 41. doi:10.1186/1471-2180-13-41. PMC 3585737. PMID 23419028.
Keefe GP (July 1997). "Streptococcus agalactiae mastitis: a review". The Canadian Veterinary Journal. 38 (7): 429–437. PMC 1576741. PMID 9220132.
Cheng WN, Han SG. (2020). "Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments - A review". Asian-Australasian Journal of Animal Science. 33 (11): 1699–1713. doi:10.5713/ajas.20.0156. PMC 7649072. PMID 32777908.
Morales-Ubaldo AL, Rivero-Perez N, Valladares-Carranza B, Velázquez-Ordoñez V, Delgadillo-Ruiz L, Zaragoza-Bastida A. (2023). "Bovine mastitis, a worldwide impact disease: Prevalence, antimicrobial resistance, and viable alternative approaches". Vet Anim Sci. 21: 100306. doi:10.1016/j.vas.2023.100306. PMC 10400929. PMID 37547227.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Crestani C, Forde TL, Lycett SJ, Holmes MA, Fasth C, Persson-Waller K, Zadoks RN. (2021). "The fall and rise of group B Streptococcus in dairy cattle: reintroduction due to human-to- cattle host jumps?". Microbial Genomics. 7 (9): 000648. doi:10.1099/mgen.0.000648. PMC 8715428. PMID 34486971.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Evans JJ, Klesius PH, Pasnik DJ, Bohnsack JF (May 2009). "Human Streptococcus agalactiae isolate in Nile tilapia (Oreochromis niloticus)". Emerging Infectious Diseases. 15 (5): 774–776. doi:10.3201/eid1505.080222. PMC 2687030. PMID 19402966.
Liu G, Zhang W, Lu C (November 2013). "Comparative genomics analysis of Streptococcus agalactiae reveals that isolates from cultured tilapia in China are closely related to the human strain A909". BMC Genomics. 14: 775. doi:10.1186/1471-2164-14-775. PMC 3831827. PMID 24215651.
Thompson KD, Rodkhum C, Bunnoy A, Thangsunan P, Kitiyodom S, Sukkarun Yostawornkul J, Yata T, Pirarat N. (2023). "Addressing Nanovaccine Strategies for Tilapia". Vaccines. 11 (8): 1356. doi:10.3390/vaccines11081356. PMC 10459980. PMID 37631924.{{cite journal}}: CS1 maint: multiple names: authors list (link)

phe.org.uk

legacyscreening.phe.org.uk

UK National Screening Committee. "Current UK NSC from the UK National Screening Committee (UK NSC)". Retrieved 4 March 2021.

porodniasistentky.info

Měchurová A, Vlk R, Unzeitig V, Švihovec P, Mašata J (2013). "Diagnostika a léčba streptokoků skupiny B v těhotenství a za porodu–doporučený postup" [Diagnosis and treatment of group B streptococci during pregnancy and childbirth – recommended procedure.] (PDF). Čes Gynek. (in Czech). 78: 11–14.

ptgin.pl

Kotarski J, Heczko PB, Lauterbach R, Niemiec T, Leszczyńska- Gorzelak B (2008). "Rekomendacje polskiego towarzystwa ginekologicznego dotyczące wykrywania nosicielstwa paciorkowców grupy B (GBS) u kobiet w ciąży i zapobiegania zakażeniom u noworodków" [Recommendations Polish Gynecological Society for the detection of carriers of GBS in pregnant women and prevent infections in newborns.] (PDF). Ginekol Pol (in Polish). 79: 221–223.

ranzcog.edu.au

Royal Australian and New Zealand College of Obstetricians and Gynaecologists. RANZCOG. "Streptococcus (GBS) in Pregnancy: Screening and Management. July 2019" (PDF). Retrieved 25 November 2023.

rcog.org.uk

RCOG-GBSS. "Information for you. Group B Streptococcus (GBS) in pregnancy and newborn babies" (PDF). Retrieved 2 December 2023.

sciencedirect.com

Gillen P, Bamidele O, Healy M. (2023). "Systematic review of women's experiences of planning home birth in consultation with maternity care providers in middle to high-income countries". Midwifery. 124. doi:10.1016/j.midw.2023.103733. PMID 37307778. Retrieved 3 July 2024.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Trotter CL, Alderson M, Dangor Z, Ip M, Le Doare K, Nakabembe E, Procter SR, Sekikubo M, Lambach P. (2023). "Vaccine value profile for Group B streptococcus". Vaccine. 41: Suppl 2:S41-S52. doi:10.1016/j.vaccine.2023.04.024. PMID 37951694. Retrieved 7 July 2024.{{cite journal}}: CS1 maint: multiple names: authors list (link)

semanticscholar.org

api.semanticscholar.org

"Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797". Obstetrics and Gynecology. 135 (2): e51 – e72. February 2020. doi:10.1097/AOG.0000000000003668. PMID 31977795. S2CID 210891255.
Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R (2008). "Prevalence of maternal group B streptococcal colonisation in European countries". Acta Obstetricia et Gynecologica Scandinavica. 87 (3): 260–271. doi:10.1080/00016340801908759. PMID 18307064. S2CID 25897076.
Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, et al. (September 2012). "Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project". European Journal of Clinical Microbiology & Infectious Diseases. 31 (9): 2097–2104. doi:10.1007/s10096-012-1559-0. PMID 22314410. S2CID 15588906.
Muller AE, Oostvogel PM, Steegers EA, Dörr PJ (2016). "Morbidity related to maternal group B streptococcal infections". Acta Obstetricia et Gynecologica Scandinavica. 85 (9): 1027–1037. doi:10.1080/00016340600780508. PMID 16929406. S2CID 11745321.
Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, et al. (July 2012). "Long-term outcomes of group B streptococcal meningitis". Pediatrics. 130 (1): e8-15. doi:10.1542/peds.2011-3453. PMID 22689869. S2CID 1013682.
Puopolo KM, Lynfield R, Cummings JJ (August 2019). "Management of Infants at Risk for Group B Streptococcal Disease". Pediatrics. 144 (2): e20191881. doi:10.1542/peds.2019-1881. PMID 31285392. S2CID 195843897.
Polin RA (May 2012). "Management of neonates with suspected or proven early-onset bacterial sepsis". Pediatrics. 129 (5): 1006–1015. doi:10.1542/peds.2012-0541. PMID 22547779. S2CID 230591.
Martinez E, Mintegi S, Vilar B, Martinez MJ, Lopez A, Catediano E, Gomez B (May 2015). "Prevalence and predictors of bacterial meningitis in young infants with fever without a source". The Pediatric Infectious Disease Journal. 34 (5): 494–498. doi:10.1097/inf.0000000000000629. PMID 25461476. S2CID 43717212.
Baker CJ, Edwards MS, Kasper DL (October 1981). "Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection". Pediatrics. 68 (4): 544–549. doi:10.1542/peds.68.4.544. PMID 7033911. S2CID 38905874.
Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT (February 2012). "Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis". Lancet. 379 (9815): 547–556. doi:10.1016/s0140-6736(11)61651-6. PMID 22226047. S2CID 15438484.
de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M (January 1998). "Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus". Obstetrics and Gynecology. 91 (1): 112–114. doi:10.1016/s0029-7844(97)00587-5. PMID 9464732. S2CID 43765652.
Berardi A, Rossi C, Biasini A, Minniti S, Venturelli C, Ferrari F, Facchinetti F (April 2011). "Efficacy of intrapartum chemoprophylaxis less than 4 hours duration". The Journal of Maternal-Fetal & Neonatal Medicine. 24 (4): 619–625. doi:10.3109/14767058.2010.511347. PMID 20828241. S2CID 6697604.
"Prevention of Early-onset Neonatal Group B Streptococcal Disease: Green-top Guideline No. 36". BJOG. 124 (12): e280 – e305. November 2017. doi:10.1111/1471-0528.14821. PMID 28901693. S2CID 32700635.
Sutkin G, Krohn MA, Heine RP, Sweet RL (March 2005). "Antibiotic prophylaxis and non-group B streptococcal neonatal sepsis". Obstetrics and Gynecology. 105 (3): 581–586. doi:10.1097/01.aog.0000153492.30757.2f. PMID 15738028. S2CID 22019440.
Schrag SJ, Hadler JL, Arnold KE, Martell-Cleary P, Reingold A, Schuchat A (August 2006). "Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use". Pediatrics. 118 (2): 570–576. doi:10.1542/peds.2005-3083. PMID 16882809. S2CID 34908773.
Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, et al. (December 2009). "Chlorhexidine maternal-vagina, and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial". Lancet. 374 (9705): 1909–1916. doi:10.1016/S0140-6736(09)61339-8. PMID 19846212. S2CID 23418670.
Clifford V, Garland SM, Grimwood K (September 2012). "Prevention of neonatal group B streptococcus disease in the 21st century". Journal of Paediatrics and Child Health. 48 (9): 808–815. doi:10.1111/j.1440-1754.2011.02203.x. PMID 22151082. S2CID 36906520.
Giménez M, Sanfeliu I, Sierra M, et al. (2015). "[Group B streptococcal early-onset neonatal sepsis in the area of Barcelona (2004-2010). Analysis of missed opportunities for prevention]". Enfermedades Infecciosas y Microbiologia Clinica. 33 (7): 446–450. doi:10.1016/j.eimc.2014.10.015. PMID 25541009. S2CID 196362631.
Håkansson S, Axemo P, Bremme K, et al. (January 2008). "Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation". Acta Obstetricia et Gynecologica Scandinavica. 87 (1): 50–58. doi:10.1080/00016340701802888. PMID 18158627. S2CID 38090766.
Kaambwa B, Bryan S, Gray J, Milner P, Daniels J, Khan KS, Roberts TE (December 2010). "Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour". BJOG. 117 (13): 1616–1627. doi:10.1111/j.1471-0528.2010.02752.x. PMID 21078057. S2CID 25561127.
Vergnano S, Embleton N, Collinson A, Menson E, Russell AB, Heath P (January 2010). "Missed opportunities for preventing group B streptococcus infection". Archives of Disease in Childhood. Fetal and Neonatal Edition. 95 (1): F72 – F73. doi:10.1136/adc.2009.160333. PMID 19439431. S2CID 38297857.
Siegel JD, Cushion NB (May 1996). "Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth". Obstetrics and Gynecology. 87 (5 Pt 1): 692–698. doi:10.1016/0029-7844(96)00004-x. PMID 8677068. S2CID 40716699.
Valkenburg-van den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, Dekker FW, Dörr PJ, Sprij AJ (2010). "Timing of group B streptococcus screening in pregnancy: a systematic review". Gynecologic and Obstetric Investigation. 69 (3): 174–183. doi:10.1159/000265942. PMID 20016190. S2CID 26709882.
Hicks P, Diaz-Perez MJ (2009). "Patient self-collection of group B streptococcal specimens during pregnancy" (PDF). Journal of the American Board of Family Medicine. 22 (2): 136–140. doi:10.3122/jabfm.2009.02.080011. PMID 19264936. S2CID 2208746.
Odubamowo K, Garcia M, Muriithi F, Ogollah R, Daniels JP, Walker KF (2023). "Self-collected versus health-care professional taken swab for identification of vaginal-rectal colonisation with group B streptococcus in late pregnancy: a systematic review". Eur J Obstet Gynecol Reprod Biol. 286: 95–101. doi:10.1016/j.ejogrb.2023.05.027. PMID 37229964. S2CID 258860996. Retrieved 27 November 2023.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (September 2019). "Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 322 (12): 1188–1194. doi:10.1001/jama.2019.13069. PMID 31550038. S2CID 202746652.
Berardi A, Lugli L, Baronciani D, Rossi C, Ciccia M, Creti R, et al. (February 2010). "Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach". The Pediatric Infectious Disease Journal. 29 (2): 115–121. doi:10.1097/inf.0b013e3181b83cd9. PMID 19915512. S2CID 31548613.
"Prevention of Early-onset Neonatal Group B Streptococcal Disease: Green-top Guideline No. 36". BJOG. 124 (12): e280 – e305. November 2017. doi:10.1111/1471-0528.14821. PMID 28901693. S2CID 32700635.
Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. (January 2004). "Group B streptococcal disease in UK and Irish infants younger than 90 days". Lancet. 363 (9405): 292–294. doi:10.1016/s0140-6736(03)15389-5. PMID 14751704. S2CID 22371160.
Brigtsen AK, Jacobsen AF, Dedi L, Melby KK, Fugelseth D, Whitelaw A (2015). "Maternal Colonization with Group B Streptococcus Is Associated with an Increased Rate of Infants Transferred to the Neonatal Intensive Care Unit". Neonatology. 108 (3): 157–163. doi:10.1159/000434716. PMID 26182960. S2CID 24711146.
Carbonell-Estrany X, Figueras-Aloy J, Salcedo-Abizanda S, de la Rosa-Fraile M (March 2008). "Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection". Archives of Disease in Childhood. Fetal and Neonatal Edition. 93 (2): F85 – F89. doi:10.1136/adc.2007.119958. PMID 17704105. S2CID 10300571.
Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, Breathnach A, Russell AB (June 2003). "Estimated early-onset group B streptococcal neonatal disease". Lancet. 361 (9373): 1953–1954. doi:10.1016/S0140-6736(03)13553-2. PMID 12801740. S2CID 33025300.
Money D, Allen VM (August 2018). "N^o 298 - Prévention de l'infection néonatale à streptocoques du groupe B d'apparition précoce". Journal of Obstetrics and Gynaecology Canada. 40 (8): e675 – e686. doi:10.1016/j.jogc.2018.05.033. PMID 30103892. S2CID 51980587.
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe (2007). "[Prevention of neonatal infection with Streptococcus Group B. Expert correspondence no. 19 of 29th December 2006]". Gynäkologisch-geburtshilfliche Rundschau. 47 (2): 103–104. doi:10.1159/000100342. PMID 17440274. S2CID 77887846.
Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. (December 2008). "Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis". The Pediatric Infectious Disease Journal. 27 (12): 1057–1064. doi:10.1097/inf.0b013e318180b3b9. PMID 18989238. S2CID 1533957.
Davies HG, Carreras-Abad C, Le Doare K, Heath PT (June 2019). "Group B Streptococcus: Trials and Tribulations". The Pediatric Infectious Disease Journal. 38 (6S Suppl 1): S72 – S76. doi:10.1097/INF.0000000000002328. PMID 31205250. S2CID 189943251. Retrieved 26 November 2023.
Madhi SA (June 2023). "Potential for Maternally Administered Vaccines for Infant Group B Streptococcus". New England Journal of Medicine. 389 (3): 215–227. doi:10.1056/NEJMoa2116045. hdl:2263/94684. PMID 37467497. S2CID 259995252.
Ruegg PL (December 2017). "A 100-Year Review: Mastitis detection, management, and prevention". Journal of Dairy Science. 100 (12): 10381–10397. doi:10.3168/jds.2017-13023. PMID 29153171. S2CID 6122209. Retrieved 26 November 2023.
Zhang D, Gao Y, Li Q, Ke X, Liu Z, Lu M, Shi C (March 2020). "An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus)". Fish & Shellfish Immunology. 98: 853–859. Bibcode:2020FSI....98..853Z. doi:10.1016/j.fsi.2019.11.044. PMID 31751658. S2CID 208226408.

seq.es

Alós Cortés JI, Andreu Domingo A, Arribas Mir L, Cabero Roura L, Cueto Lopez M, López Sastre J, et al. (March 2012). "[Prevention of perinatal group B Streptococcal disease. Updated Spanish recommendations 2012]" (PDF). Revista Espanola de Quimioterapia. 25 (1): 79–88. PMID 22488547. Retrieved 25 November 2019.

tdlpathology.com

"Testing for Group B Streptococcus". The Doctors Laboratory. Archived from the original on 4 March 2016. Retrieved 20 November 2021.

ulg.ac.be

orbi.ulg.ac.be

Belgian Health Council. "Prevention of perinatal group B streptococcal infections. Guidelines. 2003" (PDF). Archived from the original (PDF) on 4 March 2016. Retrieved 25 November 2023.

vaczine-analytics.com

"MarketVIEW: Group B Streptococcus vaccines". VacZine Analytics. Retrieved 26 November 2023.

web.archive.org

"Testing for Group B Streptococcus". The Doctors Laboratory. Archived from the original on 4 March 2016. Retrieved 20 November 2021.
Belgian Health Council. "Prevention of perinatal group B streptococcal infections. Guidelines. 2003" (PDF). Archived from the original (PDF) on 4 March 2016. Retrieved 25 November 2023.
World Health Organization. "GBS vaccine research and development technical roadmap and WHO Preferred Product Characteristics". Archived from the original on 22 April 2017. Retrieved 26 November 2023.

who.int

iris.who.int

World Health Organization. "Group B streptococcus vaccine: full value of vaccine assessment" (PDF). Retrieved 6 July 2024.

who.int

World Health Organization. "GBS vaccine research and development technical roadmap and WHO Preferred Product Characteristics". Archived from the original on 22 April 2017. Retrieved 26 November 2023.

wiley.com

obgyn.onlinelibrary.wiley.com

Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R (2008). "Prevalence of maternal group B streptococcal colonisation in European countries". Acta Obstetricia et Gynecologica Scandinavica. 87 (3): 260–271. doi:10.1080/00016340801908759. PMID 18307064. S2CID 25897076.

worldcat.org

search.worldcat.org

Raabe, Vanessa N.; Shane, Andi L. (March 2019). "Group B Streptococcus (Streptococcus agalactiae)". Microbiology Spectrum. 7 (2): 10.1128/microbiolspec.GPP3–0007–2018. doi:10.1128/microbiolspec.GPP3-0007-2018. ISSN 2165-0497. PMC 6432937. PMID 30900541.

zenodo.org

Schrag SJ, Verani JR (August 2013). "Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine". Vaccine. 31 (Suppl 4): D20 – D26. doi:10.1016/j.vaccine.2012.11.056. PMC 11843781. PMID 23219695.
Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. (December 2008). "Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis". The Pediatric Infectious Disease Journal. 27 (12): 1057–1064. doi:10.1097/inf.0b013e318180b3b9. PMID 18989238. S2CID 1533957.